PharmAthene Inc.: Government giving Emergent BioSolutions unfair advantage in anthrax contracting
Annapolis-based biodefense company PharmAthene Inc. filed a complaint against the Department of Health and Human Services, claiming it is giving a de facto sole-source anthrax contract to competitor Emergent BioSolutions Inc. with its latest solicitation.
In a protest filed with the U.S. Government Accountability Office, officials from PharmAthene said the solicitation was written in a way that eliminated competition and ensured that an award for a next-generation anthrax vaccine would go to Gaithersburg-based…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tina Reed Source Type: news
More News: Anthrax | Anthrax Vaccine | Biotechnology | Contracts | Department of Health | Government | Health | Health Management | Vaccines